The UCI announced this morning that Dutch cyclocross racer Denise Betsema was notified of adverse findings in her drug test. 

In a press release, the UCI announced that "Betsema was notified of an Adverse Analytical Finding of Endogenous Anabolic Androgenic Steroid administered exogenously in a sample collected on 27 January 2019 during the Telenet UCI Cyclo-cross World Cup in Hoogerheide, Netherlands." 

As a relative newcomer to the cyclocross scene, Betsema took the win at the World Cup in Koksijde in 2018, cementing her as one of the top riders to watch heading into World Championships. 

That win—along with the other 14 victories this past season—scored her a full-time contract with her team, Marlux-Bingoal. 

The 26-year-old went on to place fifth at the European Championships and fourth at the World Championships in Denmark. She placed seventh in Hoogerheide, where the anti-doping test was administered.

Betsema has the right to request and attend the analysis of her B sample, but has been provisionally suspended until the adjudication of the procedure. 

Betsema has made a statement, telling NOS, a Dutch news site, "I am disappointed because I am absolutely innocent. I am going to challenge this and will request a counter-expertise." (Editor note: This quote has been translated.)

The UCI has yet to comment further on the case.